CA2998357C - Compositions comprenant un ester anticholinergique doux - Google Patents

Compositions comprenant un ester anticholinergique doux

Info

Publication number
CA2998357C
CA2998357C CA2998357A CA2998357A CA2998357C CA 2998357 C CA2998357 C CA 2998357C CA 2998357 A CA2998357 A CA 2998357A CA 2998357 A CA2998357 A CA 2998357A CA 2998357 C CA2998357 C CA 2998357C
Authority
CA
Canada
Prior art keywords
hydroxyacetoxy
cyclopentyl
phenyl
composition according
methylpyrrolidinium bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2998357A
Other languages
English (en)
Other versions
CA2998357A1 (fr
Inventor
Nicholas S. Bodor
Original Assignee
Bodor Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Laboratories Inc filed Critical Bodor Laboratories Inc
Priority claimed from PCT/US2016/050385 external-priority patent/WO2017044412A1/fr
Publication of CA2998357A1 publication Critical patent/CA2998357A1/fr
Application granted granted Critical
Publication of CA2998357C publication Critical patent/CA2998357C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des formulations intra-orales comprenant des alkylesters anticholinergiques doux, lesquelles sont utiles pour traiter les états de salivation excessive chez des sujets, tels que des êtres humains, atteints de sialorrhée. De préférence, au moins un ester anticholinergique doux est contenu en quantité ou en concentration efficace dans une formulation intra-orale anhydre capable d'inhiber la salivation excessive résultant d'un état appelé sialorrhée.
CA2998357A 2015-09-11 2016-09-06 Compositions comprenant un ester anticholinergique doux Active CA2998357C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562217362P 2015-09-11 2015-09-11
US62/217,362 2015-09-11
PCT/US2016/050385 WO2017044412A1 (fr) 2015-09-11 2016-09-06 Méthodes et compositions pour esters anticholinergiques doux

Publications (2)

Publication Number Publication Date
CA2998357A1 CA2998357A1 (fr) 2017-03-16
CA2998357C true CA2998357C (fr) 2025-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
US12458625B2 (en) Methods and compositions for soft anticholinergic esters
JP5941558B2 (ja) シルデナフィルを有効成分として含有し、且つ、苦味の隠蔽された高含量速溶フィルム
SG171788A1 (en) Dosage form for insertion into the mouth
JP2000063268A (ja) 口腔粘膜付着型徐放性錠剤及び歯周疾患治療剤
CA2998357C (fr) Compositions comprenant un ester anticholinergique doux
MXPA06009094A (es) Formulaciones de liberacion controlada.
JP2000178185A (ja) 口腔粘膜付着型徐放性錠剤
CA2998353A1 (fr) Methodes et compositions pour zwitterions anticholinergiques doux
HK40110881A (zh) 软性抗胆碱能酯的方法和组合物
HK40110882A (zh) 软性抗胆碱能酯的方法和组合物
HK40111398A (zh) 软性抗胆碱能酯的方法和组合物
HK1255558B (en) Methods and compositions for soft anticholinergic esters
JP2001002590A (ja) 口腔粘膜付着型徐放性錠剤
KR101440808B1 (ko) 실데나필 또는 이의 약제학적으로 허용되는 염을 고함량으로 포함하는 속용필름